These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20810221)

  • 21. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
    Kong XB; Rubin L; Chen LI; Ciszewska G; Watanabe KA; Tong WP; Sirotnak FM; Chou TC
    Mol Pharmacol; 1992 Feb; 41(2):237-44. PubMed ID: 1311406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells.
    Marverti G; Cusumano M; Ligabue A; Di Pietro ML; Vainiglia PA; Ferrari A; Bergomi M; Moruzzi MS; Frassineti C
    J Inorg Biochem; 2008 Apr; 102(4):699-712. PubMed ID: 18082268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine.
    Guddneppanavar R; Saluta G; Kucera GL; Bierbach U
    J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.
    David-Cordonnier MH; Hildebrand MP; Baldeyrou B; Lansiaux A; Keuser C; Benzschawel K; Lemster T; Pindur U
    Eur J Med Chem; 2007 Jun; 42(6):752-71. PubMed ID: 17433851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents.
    Anderson FM; O'Hare CC; Hartley JA; Robins DJ
    Anticancer Drug Des; 2000 Apr; 15(2):119-26. PubMed ID: 10901299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents.
    Bailly C; Dassonneville L; Colson P; Houssier C; Fukasawa K; Nishimura S; Yoshinari T
    Cancer Res; 1999 Jun; 59(12):2853-60. PubMed ID: 10383146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.
    Martínez V; Burgos C; Alvarez-Builla J; Fernández G; Domingo A; García-Nieto R; Gago F; Manzanares I; Cuevas C; Vaquero JJ
    J Med Chem; 2004 Feb; 47(5):1136-48. PubMed ID: 14971893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naphthalimide intercalators with chiral amino side chains: effects of chirality on DNA binding, photodamage and antitumor cytotoxicity.
    Yang Q; Yang P; Qian X; Tong L
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6210-3. PubMed ID: 18930399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of molecules that specifically recognize and cleave apurinic sites in DNA.
    Berthet N; Boudali A; Constant JF; Decout JL; Demeunynck M; Fkyerat A; Garcia J; Laayoun A; Michon P; Lhomme J
    J Mol Recognit; 1994 Jun; 7(2):99-107. PubMed ID: 7826679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues.
    Xie G; Gupta R; Lown JW
    Anticancer Drug Des; 1995 Jul; 10(5):389-409. PubMed ID: 7639929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of intercalators and groove-binding agents with DNA triple-helical structures: the influence of ligand structure, DNA backbone modifications and sequence.
    Wilson WD; Mizan S; Tanious FA; Yao S; Zon G
    J Mol Recognit; 1994 Jun; 7(2):89-98. PubMed ID: 7826678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intercalation of organic dye molecules into double-stranded DNA. Part 2: the annelated quinolizinium ion as a structural motif in DNA intercalators.
    Ihmels H; Faulhaber K; Vedaldi D; Dall'Acqua F; Viola G
    Photochem Photobiol; 2005; 81(5):1107-15. PubMed ID: 15934789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intercalators as anticancer drugs.
    Braña MF; Cacho M; Gradillas A; de Pascual-Teresa B; Ramos A
    Curr Pharm Des; 2001 Nov; 7(17):1745-80. PubMed ID: 11562309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of atypical DNA intercalating agents in biological and in silico systems.
    Snyder RD
    Mutat Res; 2007 Oct; 623(1-2):72-82. PubMed ID: 17434187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based design of a new bisintercalating anthracycline antibiotic.
    Chaires JB; Leng F; Przewloka T; Fokt I; Ling YH; Perez-Soler R; Priebe W
    J Med Chem; 1997 Jan; 40(3):261-6. PubMed ID: 9022792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
    Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
    Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel N-(3-carboxyl-9-benzyl-carboline-1-yl)ethylamino acids: synthesis, anti-proliferation activity and two-step-course of intercalation with calf thymus DNA.
    Wu J; Cui G; Zhao M; Cui C; Peng S
    Mol Biosyst; 2007 Dec; 3(12):855-61. PubMed ID: 18000563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for cross-linking DNA by bis-intercalators with rigid and extended linkers is provided by knotting and catenation.
    Annan NK; Cook PR; Mullins ST; Lowe G
    Nucleic Acids Res; 1992 Mar; 20(5):983-90. PubMed ID: 1549510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA intercalators in cancer therapy: organic and inorganic drugs and their spectroscopic tools of analysis.
    Wheate NJ; Brodie CR; Collins JG; Kemp S; Aldrich-Wright JR
    Mini Rev Med Chem; 2007 Jun; 7(6):627-48. PubMed ID: 17584161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
    Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
    J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.